ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,961.39
      -0.18%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ProPhase Labs Inc (PRPH)

      7. ProPhase Labs Inc (PRPH) News

      PRPH

      ProPhase Labs (PRPH)

      ProPhase Labs Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PRPH
      DateTimeSourceHeadlineSymbolCompany
      05/10/20244:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
      05/09/20245:08PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PRPHProPhase Labs Inc
      05/09/20243:40PMGlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - UpdatedNASDAQ:PRPHProPhase Labs Inc
      05/09/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
      05/09/20248:00AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PRPHProPhase Labs Inc
      05/09/20248:00AMGlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.NASDAQ:PRPHProPhase Labs Inc
      05/02/20248:00AMGlobeNewswire Inc.PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9NASDAQ:PRPHProPhase Labs Inc
      04/25/20248:00AMGlobeNewswire Inc.ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024NASDAQ:PRPHProPhase Labs Inc
      04/16/20248:00AMGlobeNewswire Inc.ProPhase Labs Unveils Project ZenQ-AINASDAQ:PRPHProPhase Labs Inc
      04/10/20248:00AMGlobeNewswire Inc.ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024NASDAQ:PRPHProPhase Labs Inc
      04/01/20249:00PMGlobeNewswire Inc.ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRPHProPhase Labs Inc
      03/15/20248:00AMGlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic InitiativesNASDAQ:PRPHProPhase Labs Inc
      03/08/20248:00AMGlobeNewswire Inc.PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024NASDAQ:PRPHProPhase Labs Inc
      02/20/20248:00AMGlobeNewswire Inc.ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTNASDAQ:PRPHProPhase Labs Inc
      02/14/20244:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRPHProPhase Labs Inc
      02/14/20248:00AMGlobeNewswire Inc.ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement EquivirNASDAQ:PRPHProPhase Labs Inc
      01/30/20248:00AMGlobeNewswire Inc.ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula GenomicsNASDAQ:PRPHProPhase Labs Inc
      01/23/20248:00AMGlobeNewswire Inc.Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsNASDAQ:PRPHProPhase Labs Inc
      01/04/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
      01/04/20248:00AMGlobeNewswire Inc.ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024NASDAQ:PRPHProPhase Labs Inc
      11/13/20234:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
      11/09/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
      11/09/20238:00AMGlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023NASDAQ:PRPHProPhase Labs Inc
      11/02/20238:00AMGlobeNewswire Inc.ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern TimeNASDAQ:PRPHProPhase Labs Inc
      10/17/20238:00AMGlobeNewswire Inc.ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.NASDAQ:PRPHProPhase Labs Inc
      10/12/20238:25AMGlobeNewswire Inc.DSS Inc. Issues Letter to ShareholdersNASDAQ:PRPHProPhase Labs Inc
      10/12/20238:00AMGlobeNewswire Inc.ProPhase Labs to Present at The ThinkEquity ConferenceNASDAQ:PRPHProPhase Labs Inc
      08/11/20234:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
      08/10/202310:40AMGlobeNewswire Inc.ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.NASDAQ:PRPHProPhase Labs Inc
      08/10/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
       Showing the most relevant articles for your search:NASDAQ:PRPH